As a pivotal factor in metabolic regulation, FXR plays a crucial role in various liver diseases, including alcoholic liver disease (ALD), NAFLD, viral hepatitis, and drug-induced liver injury (Fig. 5) [101, 102]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.